Biotech

International Team to Build First Fully Synthetic Chloroplast Genomes

Camena Bioscience and Constructive Bio are partnering with global researchers to create the first fully synthetic chloroplast genomes.

Atelerix Appoints Industry Heavyweights to Board as It Gears Up for Global Expansion

Atelerix has appointed biotech leaders Sunil Shah and Dr Catherine Elton to its Board to support the company’s global commercial expansion and scale-up of its innovative cell preservation technology.

Allogene Pivoting Lymphodepletion Strategy in ALPHA3 CAR‑T Trial Following Patient Death

Allogene Therapeutics has revised its ALPHA3 CAR T trial to use only standard lymphodepletion after a patient death linked to its investigational antibody.

Centauri Therapeutics Secures $5.1M Boost from CARB-X to Advance Novel Antimicrobial into Clinical Trials

The funding will help complete non-clinical safety and efficacy studies, setting up ABX-01 for a first-in-human clinical trial planned for early 2026.

Qureight Analysis Supports Efficacy of Insilico Medicine’s AI-Discovered IPF Drug, Rentosertib, in Phase IIa Trial

Qureight’s AI-powered analysis of Insilico Medicine’s Phase IIa trial data for the novel IPF drug rentosertib supports its preliminary efficacy and underpins plans for expanded global clinical trials.

SPT Labtech and Semarion Join Forces to Advance Automated Cell-Based Assays

SPT Labtech and Semarion have partnered to create flexible, automated, and miniaturized workflows for advanced cell-based assays.